Eddie Gray

Dynavax Technologies Corporation (NASDAQ: DVAX), a clinical-stage immunotherapy company, confirmed on Thursday the U.S. Food and Drug Administration approved its two-dose vaccine  The company failed to gain approval for its therapy in February 2013 and in November 2016. But now that the...